Literature DB >> 8702662

Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function.

J Bubeck Wardenburg1, C Fu, J K Jackman, H Flotow, S E Wilkinson, D H Williams, R Johnson, G Kong, A C Chan, P R Findell.   

Abstract

Two families of tyrosine kinases, the Src and Syk families, are required for T-cell receptor activation. While the Src kinases are responsible for phosphorylation of receptor-encoded signaling motifs and for up-regulation of ZAP-70 activity, the downstream substrates of ZAP-70 are unknown. Evidence is presented herein that the Src homology 2 (SH2) domain-containing leukocyte protein of 76 kDa (SLP-76) is a substrate of ZAP-70. Phosphorylation of SLP-76 is diminished in T cells that express a catalytically inactive ZAP-70. Moreover, SLP-76 is preferentially phosphorylated by ZAP-70 in vitro and in heterologous cellular systems. In T cells, overexpression of wild-type SLP-76 results in a hyperactive receptor, while expression of a SLP-76 molecule that is unable to be tyrosine-phosphorylated attenuates receptor function. In addition, the SH2 domain of SLP-76 is required for T-cell receptor function, although its role is independent of the ability of SLP-76 to undergo tyrosine phosphorylation. As SLP-76 interacts with both Grb2 and phospholipase C-gamma1, these data indicate that phosphorylation of SLP-76 by ZAP-70 provides an important functional link between the T-cell receptor and activation of ras and calcium pathways.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702662     DOI: 10.1074/jbc.271.33.19641

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  92 in total

Review 1.  Recent developments in lymphocyte activation: linking kinases to downstream signaling events.

Authors:  J L Clements; G A Koretzky
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 2.  Adapters in lymphocyte signaling.

Authors:  Albrecht Leo; Jürgen Wienands; Gottfried Baier; Vaclav Horejsi; Burkhart Schraven
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 3.  The phospholipase C isozymes and their regulation.

Authors:  Aurelie Gresset; John Sondek; T Kendall Harden
Journal:  Subcell Biochem       Date:  2012

Review 4.  Regulation of hematopoietic cell development and activation by adapter proteins.

Authors:  Gary A Koretzky; Farhad Abtahian; Geo S Derimanov; Sally A Dmowski; Anastasia Guerriero; Martha S Jordan; Jonathan S Maltzman; Benjamin A Olenchock; Andrew L Singer; Jennifer N Wu; Xiao-Ping Zhong
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 5.  Positive and negative adaptors in T-cell signalling.

Authors:  Beverley Wilkinson; Hongyan Wang; Christopher E Rudd
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

Review 6.  Coordination of receptor signaling in multiple hematopoietic cell lineages by the adaptor protein SLP-76.

Authors:  Martha S Jordan; Gary A Koretzky
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-17       Impact factor: 10.005

Review 7.  T-cell signaling regulated by the Tec family kinase, Itk.

Authors:  Amy H Andreotti; Pamela L Schwartzberg; Raji E Joseph; Leslie J Berg
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-02       Impact factor: 10.005

8.  Independent and cooperative roles of adaptor molecules in proximal signaling during FcepsilonRI-mediated mast cell activation.

Authors:  Taku Kambayashi; Mariko Okumura; Rebecca G Baker; Chih-Jung Hsu; Tobias Baumgart; Weiguo Zhang; Gary A Koretzky
Journal:  Mol Cell Biol       Date:  2010-07-06       Impact factor: 4.272

9.  Phospholipase Cγ1 is required for pre-TCR signal transduction and pre-T cell development.

Authors:  Guoping Fu; Mei Yu; Yuhong Chen; Yongwei Zheng; Wen Zhu; Debra K Newman; Demin Wang; Renren Wen
Journal:  Eur J Immunol       Date:  2016-11-07       Impact factor: 5.532

10.  Conformational snapshots of Tec kinases during signaling.

Authors:  Raji E Joseph; Amy H Andreotti
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.